person · Reporting owner
Bujarski Robert Joseph
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | EVP & COO | October 15, 2024 | October 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date October 15, 2024 · Filed October 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,810 |
Ending reported balance
After 2024-10-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-10-15 · Grant · Acquired 390 · Balance 45,027 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-10-15 · Tax withholding · Disposed 217 · Balance 44,810 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 390 |
Reported balance
After 2024-10-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-10-15 · Exercise / conversion · Disposed 390 · Balance 390 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 1
1 source rowRow 1 · 2022-05-27 · Disposition to issuer · Disposed 29,164 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $23.41 · Expires 2025-02-05 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-27 · Disposition to issuer · Disposed 8,798 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $15.40 · Expires 2026-02-10 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-27 · Disposition to issuer · Disposed 17,596 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $21.08 · Expires 2027-02-15 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Disposition to issuer · Disposed 14,343 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 9,212 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 7,246 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $77.16 · Expires 2030-02-03 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 6,641 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $159.39 · Expires 2030-09-14 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 2,935 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 3,514 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 12,876 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 3,623 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 3,623 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 2,749 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 824 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-05-27 · Disposition to issuer · Disposed 1,033 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,033 shares will vest on November 18, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-05-27 · Disposition to issuer · Disposed 3,320 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2022-05-27 · Disposition to issuer · Disposed 1,052 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2022-05-27 · Disposition to issuer · Disposed 315 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2022-05-27 · Disposition to issuer · Disposed 941 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2022-05-27 · Disposition to issuer · Disposed 1,351 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2022-05-27 · Disposition to issuer · Disposed 405 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2022-05-27 · Disposition to issuer · Disposed 2,637 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2022-05-27 · Disposition to issuer · Disposed 1,559 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2022-05-27 · Disposition to issuer · Disposed 12,878 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2022-05-27 · Disposition to issuer · Disposed 13,545 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2022-05-27 · Disposition to issuer · Disposed 1,190 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · 2022-05-27 · Disposition to issuer · Disposed 357 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F20: 357 shares will vest on January 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3: Vested in full.
F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.
F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.
F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.
F9: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F11: 3,623 shares will vest on February 4, 2023.
F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F13: 1,033 shares will vest on November 18, 2022.
F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.
F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.
F20: 357 shares will vest on January 31, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 15, 2024 Filed Oct 17, 2024 16:48 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-115352 · ownership.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390 Underlying: Common Stock · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025. F4 · derivative.expiration_date: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:48 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 217 | $40.20 | $8,723.40 |
DisclosureSEC source: 0000950170-24-115352 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,810 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:48 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-115352 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,027 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-107434 · ownership.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 314 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 313 shares vested on September 14, 2021, 313 shares vested on September 14, 2022, 314 shares vested on September 14, 2023, and 314 shares vested on September 14, 2024. F4 · derivative.expiration_date: 313 shares vested on September 14, 2021, 313 shares vested on September 14, 2022, 314 shares vested on September 14, 2023, and 314 shares vested on September 14, 2024. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 177 | $45.47 | $8,048.19 |
DisclosureSEC source: 0000950170-24-107434 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,637 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-107434 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,814 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:58 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039665 · ownership.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Interim President, EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,850 Underlying: Common Stock · 4,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 4,925 shares vested on March 28, 2024; the remaining 9,850 shares will vest in equal installments on March 28, 2025 and March 28, 2026. F4 · derivative.expiration_date: 4,925 shares vested on March 28, 2024; the remaining 9,850 shares will vest in equal installments on March 28, 2025 and March 28, 2026. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:58 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,805 | $47.94 | $134,471.70 |
DisclosureSEC source: 0000950170-24-039665 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Interim President, EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:58 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039665 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Interim President, EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,305 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 17:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-023249 · ownership.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Interim President, EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,367 Underlying: Common Stock · 21,367 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 21,367 shares will fully vest on June 30, 2025. F2 · derivative.expiration_date: 21,367 shares will fully vest on June 30, 2025. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 19:50 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014858 · ownership.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 19:50 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,052 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014858 · ownership.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,052 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 19:50 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 180 | $68.15 | $12,267.00 |
DisclosureSEC source: 0000950170-24-014858 · ownership.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,380 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 19:50 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014858 · ownership.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,560 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 19:50 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 575 | $68.15 | $39,186.25 |
DisclosureSEC source: 0000950170-24-014858 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,245 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 19:50 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,052 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014858 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,820 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:43 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 17,905 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014147 · ownership.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,905 Underlying: Common Stock · 17,905 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 11,936 shares will vest in equal installments on February 8, 2025 and February 8, 2026; the remaining 5,969 shares will vest on February 8, 2027. F2 · derivative.expiration_date: 11,936 shares will vest in equal installments on February 8, 2025 and February 8, 2026; the remaining 5,969 shares will vest on February 8, 2027. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,660 shares vested on February 3, 2024. F5 · derivative.expiration_date: 1,660 shares vested on February 3, 2024. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 946 | $68.34 | $64,649.64 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,768 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,714 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 879 Underlying: Common Stock · 879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 879 shares vested on February 1, 2024; the remaining 879 shares will vest on February 1, 2025. F4 · derivative.expiration_date: 879 shares vested on February 1, 2024; the remaining 879 shares will vest on February 1, 2025. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 501 | $69.45 | $34,794.45 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,054 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,555 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 6,772 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,773 Underlying: Common Stock · 6,772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 6,772 shares vested on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026. F5 · derivative.expiration_date: 6,772 shares vested on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,219 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,440 Underlying: Common Stock · 3,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,219 shares vested on January 31, 2024; the remaining 6,440 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 3,219 shares vested on January 31, 2024; the remaining 6,440 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 3,857 | $68.51 | $264,243.07 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,676 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 6,772 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,533 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,924 | $68.51 | $131,813.24 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,761 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,219 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,685 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052948 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 780 Underlying: Common Stock · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. F4 · derivative.expiration_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 194 | $68.02 | $13,195.88 |
DisclosureSEC source: 0001209191-23-052948 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,466 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052948 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,660 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049795 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314 Underlying: Common Stock · 314 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 314 shares vested on September 14, 2023; the remaining 314 shares will vest on September 14, 2024. F4 · derivative.expiration_date: 314 shares vested on September 14, 2023; the remaining 314 shares will vest on September 14, 2024. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 156 | $76.37 | $11,913.72 |
DisclosureSEC source: 0001209191-23-049795 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,270 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049795 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,426 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 19:12 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021710 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,775 Underlying: Common Stock · 14,775 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F1 · derivative.exercise_date: 4,925 shares will vest on the first anniversary date of the grant date, March 28, 2024; 4,925 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 4,925 shares will vest on the third anniversary date of the grant date, March 28, 2026. F1 · derivative.expiration_date: 4,925 shares will vest on the first anniversary date of the grant date, March 28, 2024; 4,925 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 4,925 shares will vest on the third anniversary date of the grant date, March 28, 2026. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 19:12 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Option · Derivative | 14,775 | $0.00 Strike: $87.46 | $0.00 |
DisclosureSEC source: 0001209191-23-021710 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,775 Underlying: Common Stock · 14,775 shares Expires 2033-03-28 F1 · derivative.exercise_date: 4,925 shares will vest on the first anniversary date of the grant date, March 28, 2024; 4,925 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 4,925 shares will vest on the third anniversary date of the grant date, March 28, 2026. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 824 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009167 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 824 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 2,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009167 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 434 | $86.50 | $37,541.00 |
DisclosureSEC source: 0001209191-23-009167 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,112 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 824 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009167 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,546 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,381 | $86.50 | $119,456.50 |
DisclosureSEC source: 0001209191-23-009167 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,722 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 2,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009167 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,103 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,623 shares vested on February 4, 2023. F5 · derivative.expiration_date: 3,623 shares vested on February 4, 2023. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,905 | $89.70 | $170,878.50 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,354 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,259 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,660 Underlying: Common Stock · 1,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,660 shares vested on February 3, 2023; the remaining 1,660 shares will vest on February 3, 2024. F4 · derivative.expiration_date: 1,660 shares vested on February 3, 2023; the remaining 1,660 shares will vest on February 3, 2024. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 873 | $89.70 | $78,308.10 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,636 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,509 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:56 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006322 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 879 shares vested on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025. F5 · derivative.expiration_date: 879 shares vested on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.